You are using an older browser version. Please use a supported version for the best MSN experience.

25 Stocks Moving in Friday's Pre-Market Session

Benzinga logo Benzinga 11/26/2021 Lisa Levin
© Provided by Benzinga

Gainers

iSpecimen Inc. (NASDAQ: ISPC) rose 56.9% to $16.00 in pre-market trading. The company recently announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments. Allied Healthcare Products, Inc. (NASDAQ: AHPI) rose 29.6% to $6.98 in pre-market trading. Covid-related stocks surged on reports of new, heavily-mutated strain, feared to be more infectious than Delta variant. Valneva SE (NASDAQ: VALN) rose 18.1% to $58.93 in pre-market trading. Valneva recently signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID-19 vaccine candidate VLA2001, over two years. BIMI International Medical Inc. (NASDAQ: BIMI) rose 16.9% to $0.8210 in pre-market trading. BIMI recently priced its private placement for $7.8 million in proceeds. Alpha Pro Tech, Ltd (NYSE: APT) shares rose 15.2% to $5.90 in pre-market trading. Covid-related stocks surged on reports of new, heavily-mutated strain, feared to be more infectious than Delta variant. Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 11.4% to $13.31 in pre-market trading. Aptevo Therapeutics recently announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 in the treatment of AML. Preliminary data observed to date includes one complete remission. Ocugen, Inc. (NASDAQ: OCGN) rose 10.9% to $7.87 in pre-market trading. Covid-related stocks surged on reports of new, heavily-mutated strain, feared to be more infectious than Delta variant. Nautilus, Inc. (NYSE: NLS) rose 9.9% to $7.81 in pre-market trading. Co-Diagnostics, Inc (NASDAQ: CODX) rose 9.7% to $9.30 in pre-market trading. iBio, Inc. (NYSE: IBIO) rose 9.7% to $0.73 in pre-market trading. GeoVax Labs, Inc. (NASDAQ: GOVX) rose 9.5% to $4.25 in pre-market trading. GeoVax recently highlighted presentation of COVID-19 vaccine data at Vaccine World Asia Congress. Zoom Video Communications, Inc. (NASDAQ: ZM) shares rose 9.4% to $227.88 in pre-market trading amid concerns of a new COVID variant found in South Africa, which has lifted remote work and virtual communication stocks. BeyondSpring Inc. (NASDAQ: BYSI) rose 9.1% to $14.49 in pre-market trading after gaining 5% on Wednesday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

Selecta Biosciences, Inc. (NASDAQ: SELB) fell 15.1% to $2.70 in pre-market trading after the company disclosed that the FDA has issued clinical hold on its Phase 1/2 clinical trial of SEL-302 due to CMC related questions. Oncolytics Biotech Inc. (NASDAQ: ONCY) fell 14.9% to $1.60 in pre-market trading. Oncolytics Biotech will present Phase 2 triple-negative breast cancer trial update at 2021 San Antonio Breast Cancer Symposium Dec. 9. RAVE Restaurant Group, Inc. (NASDAQ: RAVE) shares fell 14.4% to $1.31 in pre-market trading after gaining 5% on Wednesday. Callon Petroleum Company (NYSE: CPE) fell 12.2% to $54.18 in pre-market trading after jumping around 6% on Wednesday. BIOLASE, Inc. (NASDAQ: BIOL) fell 12.1% to $0.4130 in pre-market trading. Biolase shares gained 12% on Wednesday after the company announced Nasdaq granted its request for a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement. Mechel PAO (NYSE: MTL) shares fell 11.1% to $2.87 in pre-market trading. Mechel recently reported Q3 sales of 102.9 billion Rubles. Carnival Corporation & plc (NYSE: CUK) fell 11% to $16.54 in pre-market trading after a new COVID variant was discovered in South Africa, which has clouded travel outlook. Canoo Inc. (NASDAQ: GOEV) shares fell 11% to $11.02 in pre-market trading after surging 7% on Wednesday. Reliance Global Group, Inc. (NASDAQ: RELI) shares fell 10% to $2.33 in pre-market trading following a 7% gain on Wednesday. Royal Caribbean Cruises Ltd. (NYSE: RCL) fell 9.8% to $70.55 in pre-market trading after a new COVID variant was discovered in South Africa, which has clouded travel outlook. Gracell Biotechnologies Inc. (NASDAQ: GRCL) fell 8.2% to $6.51 in pre-market trading. Gracell Biotechnologies recently reported members of its senior management team intend to use personal funds to buy up to $2 million in company ADSs in the open market over the next 3 months. NOV Inc. (NYSE: NOV) shares fell 7.4% to $11.91 in pre-market trading. NOV, last week, said it reinstated regular quarterly dividend of $0.05 per share.
AdChoices
AdChoices
AdChoices

More From Benzinga

image beaconimage beaconimage beacon